Avita Medical Ltd (RCEL)

[Align]

Melody will have a more accurate view.

My guess is although the recent news will bode well for the company in the future, I think it comes down to revenue. The market wants to see higher revenue growth than the 20% YoY guidance.. 20% QoQ would turn the share price around.

In the quarterly call, the CFO mentioned a potential future capital raise in 2023-24 which probably doesn’t help either, even if it’s to fund the future E.B and Rejuvenation multi billion dollar markets.

In saying that, I think the company will follow through with their corporate strategies in the medium to long term which will sort out the share price.